Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma-Reference-Cited by-同舟云学术

Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma

Published:2021-09-01 Issue:9 Volume:7 Page:1313
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Leary Sarah E. S.¹²³,Packer Roger J.⁴,Li Yimei⁵,Billups Catherine A.⁵,Smith Kyle S.⁶,Jaju Alok⁷,Heier Linda⁸,Burger Peter⁹,Walsh Karin¹⁰,Han Yuanyuan⁵,Embry Leanne¹¹,Hadley Jennifer⁶,Kumar Rahul⁶,Michalski Jeff¹²,Hwang Eugene¹³,Gajjar Amar¹⁴,Pollack Ian F.¹⁵,Fouladi Maryam¹⁶,Northcott Paul A.⁶,Olson James M.¹²³

Affiliation:

1. Cancer and Blood Disorders Center, Seattle Children’s, Seattle, Washington

2. Department of Pediatrics, University of Washington School of Medicine, Seattle

3. Fred Hutchinson Cancer Research Center, Seattle, Washington

4. Center for Neuroscience and Behavioral Health, Children’s National Hospital, Washington, DC

5. Department of Biostatistics, St Jude Children’s Research Hospital, Memphis, Tennessee

6. Department of Developmental Neurobiology, St Jude Children’s Research Hospital, Memphis, Tennessee

7. Department of Radiology, Ann and Robert H. Lurie Children’s Hospital, Chicago, Illinois

8. Department of Radiology, NYP/Weill Cornell Medical Center, New York, New York

9. Sidney Kimmel Cancer Center, Department of Pathology, Johns Hopkins University, Baltimore, Maryland

10. Division of Neuropsychology, Children’s National Hospital, Washington, DC

11. Pediatric Hematology/Oncology, UT Health San Antonio, San Antonio, Texas

12. Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri

13. Center for Cancer and Blood Disorders, Children’s National Hospital, Washington, DC

14. Department of Oncology, St Jude Children’s Research Hospital, Memphis, Tennessee

15. Department of Neurosurgery, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania

16. Pediatric Hematology & Oncology, Nationwide Children’s Hospital, Columbus, Ohio

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2782033/jamaoncology_leary_2021_oi_210036_1631288533.71835.pdf

Reference32 articles.

1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012.;Ostrom;Neuro Oncol,2015

2. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.;Packer;J Clin Oncol,2006

3. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.;Gajjar;Lancet Oncol,2006

4. Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children’s Oncology Group phase I/II study.;Jakacki;J Clin Oncol,2012

5. Survival after relapse of medulloblastoma.;Koschmann;J Pediatr Hematol Oncol,2016

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of Systemic Therapy in Medulloblastoma Including Irradiation-Sparing Approaches;Diagnostics;2023-12-16

2. International experience by using of the SJMB protocols in treatment of children with medulloblastoma in the age group over 3 years (literature review);Journal of Modern Oncology;2023-12-10

3. Adolescents and Young Adults With Cancer: CNS Tumors;Journal of Clinical Oncology;2023-12-08

4. Results of a multicenter study of the treatment of WNT medulloblastomas in children;Russian Journal of Pediatric Hematology and Oncology;2023-11-29

5. Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier;Cancer Medicine;2023-11-23